Abstract
Assessment of the effectiveness compared with alternative treatment(s) plays an important role in many jurisdictions in determining the reimbursement status of pharmaceuticals. This type of assessment is often referred to as a relative effectiveness assessment (REA) and is carried out by many jurisdictions. Increased sharing of information across jurisdictions may save costs and reduce duplication. The objective of this study was to explore the main similarities and differences in the major methodological aspects of REA in multiple jurisdictions.
Original language | English |
---|---|
Pages (from-to) | 954-60 |
Number of pages | 7 |
Journal | Value in Health |
Volume | 15 |
Issue number | 6 |
DOIs | |
Publication status | Published - Sept 2012 |